SCHEMBL22012871

SCHEMBL22012871

NS(=O)(=O)c1cc(CBr)cs1

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA2 P00918 20/20 0.46
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA9 Q16790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24670395 0.82 CA2 (0.42) CA2
SCHEMBL21963164 0.80 CA2 (0.50) CA2
SCHEMBL7145362 0.80 CA2 (0.50) CA2CA12CA1CA9
SCHEMBL9829759 0.77 CA2 (0.66) CA2
SCHEMBL22012875 0.76 CA2 (0.59) CA2
SCHEMBL9393039 0.76 CA2 (0.48) CA2
SCHEMBL10369923 0.74 CA2 (0.69) CA2
SCHEMBL24670388 0.74 CA2 (0.50) CA2
SCHEMBL2008068 0.74 CA2 (0.52) CA2CA12CA1CA9
SCHEMBL10391021 0.72 CA2 (0.60) CA2CA12CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102576-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed